Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Author Archive for: wenche
About Wenche Gerhardsen
Wenche Gerhardsen is Head of Communications at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator. You can reach her at email@example.com
Entries by Wenche Gerhardsen
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
Dette er endringene i eierstrukturen for Oslo Cancer Cluster (OCC) Innovasjonspark i januar 2020.
Kaare R. Norum died on Friday 22 November 2019, at an age of 86 years.
Næringskomiteens innstilling om Helsenæringsmeldingen er klar. Dette mener Oslo Cancer Cluster om tre viktige temaer i innstillingen.
Cancer Registry of Norway has released the report Cancer in Norway. These are the main points.
OCC Incubator was recently rated among the top 20 European biotech incubators. Here’s why!
I Statsbudsjettet 2020 foreslår regjeringen flere temaer som er relevante for Oslo Cancer Cluster.
A new clinical study indicates that medical nutrition can improve overall survival in lung cancer patients.
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.
We proudly present the new members that have joined our organisation during the second quarter of 2019.
SINTEF is looking for new partners to develop methodology for cancer immunotherapy.
Rapporten gir innsikt i en næring som i 2018 omsatte for 142 milliarder kroner.
Made in Oslo, the first ever Norwegian CAR T cell is now a fact.
A new study may potentially enable scientists to provide cancer immunotherapy that is cheaper, faster and more manageable.
Contact us >
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.
We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals and organizations – all working in the cancer field.